Zr-Labeled Multifunctional Liposomes Conjugate Chitosan for PET-Trackable Triple-Negative Breast Cancer Stem Cell Targeted Therapy.

PURPOSE

Therapy for triple-negative breast cancer (TNBC) is a global problem due to lack of specific targets for treatment selection. Cancer stem cells (CSCs) are responsible for tumor formation and recurrence but also offer a promising target for TNBC-targeted therapy. Here, zirconium-89 (Zr)-labelled multifunctional liposomes (MLPs) surface-decorated with chitosan (CS) were fabricated to specifically target and trace cluster of differentiation 44 (CD44) TNBC CSCs specifically.

PATIENTS AND METHODS

The biological basis of CS targeting CD44 for cancer therapy was investigated by detecting the expression of CD44 in TNBC CSCs and TNBC tissues. Molecular docking and dynamics simulations were performed to investigate the molecular basis of CS targeting CD44 for cancer therapy. Gambogic acid (GA)-loaded, Zr@CS-MLPs (Zr-CS-GA-MLPs) were prepared, and their uptake and biodistribution were observed. The anti-tumor efficacy of Zr@CS-GA-MLPs was investigated in vivo.

RESULTS

CD44 is overexpressed in TNBC CSCs and tissues. Molecular docking and dynamics simulations showed that CS could be stably docked into the active site of CD44 in a reasonable conformation. Furthermore, Zr@CS-GA-MLPs were able to bind specifically to CD44 TNBC stem-like cells and accumulated in tumors of xenograft-bearing mice with excellent radiochemical stability. Zr@CS-GA-MLPs loaded with GA showed remarkable anti-tumor efficacy in vivo.

CONCLUSION

The GA-loaded, Zr-labelled, CS-decorated MLPs developed in this study represent a novel strategy for TNBC imaging and therapy.